Nordnet Indexfond Global vs UBS Lux Equity Fund Biotech USD

Nordnet Indexfond Global vs UBS Lux Equity Fund Biotech USD

1. Nordnet Indexfond Global

  • Security

    Nordnet Indexfond Global ESG

  • Fee

    0.20%

  • ISIN

    IE00BMTD2G30

  • Holdings

    10

  • Number of owning funds

    2

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

Fund Holdings

We have information about 22 holdings in Nordnet Indexfond Global, where the largest holding is Salesforce.com (0.78), followed by AstraZeneca (0.64) and Merck & Co (0.64). In comparison with UBS Lux Equity Fund Biotech USD, we have 14 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Vertex (9.9) and Moderna (9.21).

All Holdings

Here we compare the holdings in Nordnet Indexfond Global and UBS Lux Equity Fund Biotech USD.

Nordnet Indexfond Global UBS Lux Equity Fund Biotech USD
1. Salesforce.com Inc
USA
0.78 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. AstraZeneca
Sweden UK
0.64 %
2. Vertex Pharmaceuticals Inc
9.9 %
3. Merck & Co Inc
Germany
0.64 %
3. Moderna Inc
9.21 %
4. IBM Corp
USA
0.64 %
4. Alnylam Pharmaceuticals Inc
6.54 %
5. GE Aerospace
USA
0.62 %
5. AbbVie Inc
USA
5.52 %
6. McDonald's Corp
USA
0.61 %
6. Gilead Sciences Inc
USA
4.66 %
7. Linde Plc
Ireland
0.61 %
7. Amgen Inc
4.32 %
8. Accenture Plc
Ireland
0.6 %
8. BioNTech SE
4.13 %
9. HSBC Holdings PLC
UK
0.59 %
9. Karuna Therapeutics Inc
3.75 %
10. PepsiCo Inc
USA
0.58 %
10. Royalty Pharma Plc
3.28 %

The list of fund holdings was last updated on April 17, 2025.